Reference typing report for complement component C3. 1998

C Rittner, and D Bellavia, and G Geserick, and A Frank, and B Stradmann-Bellinghausen
Institute of Legal Medicine, Johannes Gutenberg University, Mainz, Germany.

A comparison of five C3 variant samples has been performed by conventional high-voltage gel electrophoresis in three laboratories (Palermo, Berlin and Mainz). Local designation was shown within SD = +/-0.75 mm migration distance in the Mainz laboratory. Methodological modifications by laboratories were not accounted for (cooling temperature, relative mobilities between runs). In parallel, all reference samples were also sequenced after exon-specific amplification. As a result, two variants with identical final designations and two variants with different mobilities were shown to conform at the molecular basis exhibiting an amino acid exchange that causes the corresponding change in relative mobility as compared to normal C3F and C3S.

UI MeSH Term Description Entries
D012015 Reference Standards A basis of value established for the measure of quantity, weight, extent or quality, e.g. weight standards, standard solutions, methods, techniques, and procedures used in diagnosis and therapy. Standard Preparations,Standards, Reference,Preparations, Standard,Standardization,Standards,Preparation, Standard,Reference Standard,Standard Preparation,Standard, Reference
D001797 Blood Protein Electrophoresis Electrophoresis applied to BLOOD PROTEINS. Hemoglobin Electrophoresis,Electrophoresis, Blood Protein,Electrophoresis, Hemoglobin,Protein Electrophoresis, Blood
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014644 Genetic Variation Genotypic differences observed among individuals in a population. Genetic Diversity,Variation, Genetic,Diversity, Genetic,Diversities, Genetic,Genetic Diversities,Genetic Variations,Variations, Genetic

Related Publications

C Rittner, and D Bellavia, and G Geserick, and A Frank, and B Stradmann-Bellinghausen
January 1998, Experimental and clinical immunogenetics,
C Rittner, and D Bellavia, and G Geserick, and A Frank, and B Stradmann-Bellinghausen
January 1998, Experimental and clinical immunogenetics,
C Rittner, and D Bellavia, and G Geserick, and A Frank, and B Stradmann-Bellinghausen
January 1998, Experimental and clinical immunogenetics,
C Rittner, and D Bellavia, and G Geserick, and A Frank, and B Stradmann-Bellinghausen
January 1990, Complement and inflammation,
C Rittner, and D Bellavia, and G Geserick, and A Frank, and B Stradmann-Bellinghausen
January 1998, Experimental and clinical immunogenetics,
C Rittner, and D Bellavia, and G Geserick, and A Frank, and B Stradmann-Bellinghausen
January 2006, Advances in experimental medicine and biology,
C Rittner, and D Bellavia, and G Geserick, and A Frank, and B Stradmann-Bellinghausen
January 1990, Methods in enzymology,
C Rittner, and D Bellavia, and G Geserick, and A Frank, and B Stradmann-Bellinghausen
November 1999, Nihon rinsho. Japanese journal of clinical medicine,
C Rittner, and D Bellavia, and G Geserick, and A Frank, and B Stradmann-Bellinghausen
April 2005, Immunology letters,
C Rittner, and D Bellavia, and G Geserick, and A Frank, and B Stradmann-Bellinghausen
January 1974, Vox sanguinis,
Copied contents to your clipboard!